Company Performance Metrics
GLAX is a biotechnology and medical research company that focuses on drug discovery, development, and regulatory support for human diseases. GLAX conducts research in oncology, diabetes, neurological disorders, and infectious diseases and develops therapeutics targeting dysregulated molecular pathways. The company provides contract research
services spanning drug development, clinical pharmacology, and commercialization support for pharmaceutical and healthcare clients. Its services include molecular modeling, protocol development, clinical trial design, pharmacokinetics and pharmacodynamics studies, animal studies, and medical, clinical, and regulatory support. GLAX also offers custom synthesis, production, and distribution of small molecules, natural products, and antibodies for research and clinical use. The organization applies precision medicine concepts to analyze molecular data and support individualized therapeutic strategies.
